Abstract: A vehicle operation management system for managing an operation of a vehicle includes: an on-vehicle device mounted on the vehicle, the on-vehicle device being configured to collect driving data of the vehicle and enable a driver to perform an operation for setting an activity state of the vehicle; a server installed outside the vehicle, the server being configured to communicate with the on-vehicle device and store the driving data of the vehicle; and a terminal device configured to communicate with the server, the terminal device being capable of bringing outside the vehicle. An operation signal output from the terminal device in response to an operation by the driver is transmitted to the server. The on-vehicle device is configured to set the activity state on the basis of the operation signal the server has received from the terminal device.

Abstract: A vehicle operation management system for managing an operation of a vehicle includes: an on-vehicle device mounted on the vehicle, the on-vehicle device being configured to collect driving data of the vehicle and enable a driver to perform an operation for setting an activity state of the vehicle; a server installed outside the vehicle, the server being configured to communicate with the on-vehicle device and store the driving data of the vehicle; and a terminal device configured to communicate with the server, the terminal device being capable of bringing outside the vehicle. An operation signal output from the terminal device in response to an operation by the driver is transmitted to the server. The on-vehicle device is configured to set the activity state on the basis of the operation signal the server has received from the terminal device.

Abstract: A gateway apparatus for performing transfer control of frame data between communication channels includes a routing map that stores ID information about the frame data and information about a communication channel that uses the ID information, and a search engine unit that routes the frame data to a transfer destination on the basis of the ID information of the frame data received and the routing map. The search engine unit does not transfer the frame data to the transfer destination when the ID information about the frame data received is ID information that is not used in the communication channel through which the frame data is received.

Abstract: An error detector has a parity bit generator which generates error detection data for data strings sent from a CPU I/F to a memory, a parity checker which detects an error in the data strings output from the memory based on the error detection data, and a selector circuit which switchingly outputs the data from the parity bit generator and the data from a CPU which sends diagnostic data. While the selector circuit is switched to output the data from the CPU, based on the error detection data output from the selector circuit, the error detector conducts a failure diagnosis of error detection functions including at least one of the parity bit generator and the parity checker.

Abstract: A data search device that is provided in a communication apparatus detects a memory area storing data to be transmitted from a memory unit having memory areas defined by IDs allotted to data. The data search device includes: a first flag that is provided for each of the memory areas of the memory unit, and indicate whether the data in the corresponding memory area is updated; a second flag that is provided for each group consisting of a predetermined number of the first flags, and indicates a data update state when at least one set of data in the first flags in the corresponding group indicates an updated state; and a search control unit that detects the memory area storing the data to be transmitted, by searching for the corresponding first flag after detecting the second flag.

Abstract: A gateway apparatus for performing transfer control of frame data between a plurality of different communication channels is provided with a time stamp unit for adding time stamp information to received frame data and a data discarding unit for determining processing delay of the frame data or abnormality of the apparatus by referring to the time stamp information and for deleting the time stamp information added to the frame data at the time of sending the frame data.

Abstract: Functional information acquired before and after an event occurrence is held on an on-chip MRAM built in a data processor, thus preventing the held functional information from being falsified and erased. An automobile recorder of the present invention comprises a one-chip data processor coupled to signal lines transmitting functional information indicating vehicle conditions and an external memory. The data processor comprises an input circuit which takes input of functional information, an MRAM for temporarily storing functional information, and a central processing unit (CPU). The CPU performs wrap-around control for storing functional information into the MRAM. The CPU also performs disabling control for disabling storing of functional information when the amount of new information being stored on the MRAM by wrap-around control in response to and following a certain event occurrence has reached a specific quantity that is less than a storage capacity from the initial address to the end address.

Abstract: A data search device that is provided in a communication apparatus detects a memory area storing data to be transmitted from a memory unit having memory areas defined by IDs allotted to data. The data search device includes: a first flag that is provided for each of the memory areas of the memory unit, and indicate whether the data in the corresponding memory area is updated; a second flag that is provided for each group consisting of a predetermined number of the first flags, and indicates a data update state when at least one set of data in the first flags in the corresponding group indicates an updated state; and a search control unit that detects the memory area storing the data to be transmitted, by searching for the corresponding first flag after detecting the second flag.

Abstract: An error detector has a parity bit generator which generates error detection data for data strings sent from a CPU I/F to a memory, a parity checker which detects an error in the data strings output from the memory based on the error detection data, and a selector circuit which switchingly outputs the data from the parity bit generator and the data from a CPU which sends diagnostic data. While the selector circuit is switched to output the data from the CPU, based on the error detection data output from the selector circuit, the error detector conducts a failure diagnosis of error detection functions including at least one of the parity bit generator and the parity checker.

Abstract: A gateway apparatus for performing transfer control of frame data between communication channels includes a routing map that stores ID information about the frame data and information about a communication channel that uses the ID information, and a search engine unit that routes the frame data to a transfer destination on the basis of the ID information of the frame data received and the routing map. The search engine unit does not transfer the frame data to the transfer destination when the ID information about the frame data received is ID information that is not used in the communication channel through which the frame data is received.

Abstract: A gateway apparatus for performing transfer control of frame data between a plurality of different communication channels is provided with a time stamp unit for adding time stamp information to received frame data and a data discarding unit for determining processing delay of the frame data or abnormality of the apparatus by referring to the time stamp information and for deleting the time stamp information added to the frame data at the time of sending the frame data.

Abstract: The object of the present invention is to provide a prophylactic and/or therapeutic drug for obesity and obesity-associated diseasestor diabetes with a reduced risk for central side effects and high universality in usage. Another object of the present invention is to provide a pharmaceutical composition comprising a compound of the following formula: wherein Ar represents phenyl which may be substituted and/or condensed; n represents an integer of 1 to 10; R represents hydrogen or a hydrocarbon group which may be substituted, which may not be the same in its n occurrences; R may be bound to either Ar or a substituent for Ar; Y represents an amino group which may be subsituted or a nitrogen-containing saturated heterocyclic group which may be substituted, or a salt thereof, which can be used for a thermogenic agent, an antiobesity agent, a lipolytic agent, or a prophylactic and/or treating drug for obesity-associated diseases.

Abstract: An address match determining device has an address filter memory (22) for storing a matrix or table having a plurality of elements each of which is a 1-bit address match determination data indicating whether or not a corresponding N-bit address code is available, and is distinguished by a pair of a first index composed of the m most significant or high-order m bits of the corresponding address code and a second index composed of the remaining lowest or low-order (N−m) bits of the corresponding address code. A received-address latch (21) extracts the high-order m bits and remaining low-order (N−m) bits from an address code latched thereinto.

Abstract: A pharmaceutical composition for inhibiting cysteine protease which comprises a compound of the formula: ##STR1## wherein R.sup.1 is a hydrogen atom or an acyl group; R.sup.2, R.sup.3 and R.sup.4, same or different, are a bond, an amino acid residue or a group of the formula:--Y--R.sup.5 --in which R.sup.5 is a group resulting from imino group removal from an amino acid residue;Y is --O--, --S-- or --NR.sup.6 -- in which R.sup.6 is a hydrogen atom or a lower alkyl group;A is ##STR2## Z is a hydrogen atom, an acyl group or an optionally substituted hydrocarbon group; n is 1 or 2;provided that when n is 1, then A is ##STR3## and Y is --S-- or --NR.sup.6 --, and, at least one of R.sup.2, R.sup.3 and R.sup.4 is the formula --Y--R.sup.5 --, provided that when further all Y are --NR.sup.6 --, at least one of the amino acid residues is not bound to amhydrogen atom at the .alpha.-carbon thereof but substituted via carbon;provided that when n is 2 and Z is an aldehyde group, then R.sup.

Abstract: The present invention provides a cathepsin L inhibitor containing a compound of the formula: ##STR1## wherein R.sup.1 is a hydrogen atom or an arylalkyl, heterocyclic-alkyl or lower alkyl group which may be substituted; R.sup.2 and R.sup.3 independently are a hydrogen atom or a hydrocarbon residue which may be substituted; R.sup.4 is an alkanoyl, sulfonyl, carbonyloxy, carbamoyl or thiocarbamoyl group which may be substituted; X is formula: --CHO or --CH.sub.2 OB (wherein B is a hydrogen atom or a protecting group of hydroxyl group); m and n independently are an integer of 0 or 1; provided that R.sup.4 is an alkanoyl group substituted by aryl, a sulfonyl group substituted by aryl having more than 9 carbon atoms or by lower alkyl, or a carbamoyl or thiocarbamoyl group which may be substituted when R.sup.1 is an unsubstituted lower alkyl, arylalkyl on methylthioethyl group, R.sup.2 and R.sup.3 independently are a lower alkyl or arylalkyl, X is --CHO, m is 1 and n is 0 or 1, or a salt thereof.

Abstract: Disclosed are (1) a fused protein obtained by combining an antigen used for vaccine and a lymphokine by the application of gene engineering, (2) a recombinant DNA containing a nucleotide sequence coding for the above fused protein, (3) a transformant bearing the above recombinant DNA, (4) a method for producing the fused protein which comprises cultivating the above transformant, producing and accumulating the above fused protein in a culture, and collecting the fused protein, and (5) a hybrid protein obtained by chemically combining an antigen used for vaccine with a lymphokine. The resulting fused and hybrid proteins have strong immunogenicity.

Abstract: The present invention provides a cathepsin L inhibitor containing a compound of the formula: ##STR1## wherein R.sup.1 is a hydrogen atom or an arylalkyl, heterocyclic-alkyl or lower alkyl group which may be substituted; R.sup.2 and R.sup.3 independently are a hydrogen atom or a hydrocarbon residue which may be substituted; R.sup.4 is an alkanoyl, sulfonyl, carbonyloxy, carbamoyl or thiocarbamoyl group which may be substituted; X is formula: --CHO or --CH.sub.2 OB (wherein B is a hydrogen atom or a protecting group of hydroxyl group); m and n independently are an integer of 0 or 1; provided that R.sup.4 is an alkanoyl group substituted by aryl, a sulfonyl group substituted by aryl having more than 9 carbon atoms or by lower alkyl, or a carbamoyl or thiocarbamoyl group which may be substituted when R.sup.1 is an unsubstituted lower alkyl, arylalkyl on methylthioethyl group, R.sup.2 and R.sup.3 independently are a lower alkyl or arylalkyl, X is --CHO, m is 1 and n is 0 or 1, or a salt thereof.

Abstract: A switching regulator is composed of digital circuits only. A switching regulator (30) comprises a driver (2) for directly controlling the operation of a switching transistor (1), and an OR gate (6) for determining the logic issued by the driver (2). An output terminal (Q) of an RS flip-flop (5) is connected to one input end of the OR gate (6), the output of a timer (40c) is applied to a set terminal (S) of the RS flip-flop (5), and the output of a comparator (4) is applied to a reset terminal (R1) through an OR gate (7). At a non-reverse input end of the comparator (4), a reference voltage (VE) is applied by a D/A convertor (40b), while a feedback voltage (VFB) is applied to a reverse input end. Accordingly, chopping of the switching transistor (1) is done on the basis of a rectangular pulse.

Abstract: The present invention provides a cathepsin L inhibitor containing a compound of the formula: ##STR1## wherein R.sup.1 is a hydrogen atom or an arylalkyl, heterocyclic-alkyl or lower alkyl group which may be substituted; R.sup.2 and R.sup.3 independently are a hydrogen atom or a hydrocarbon residue which may be substituted; R.sup.4 is an alkanoyl, sulfonyl, carbonyloxy, carbamoyl or thiocarbamoyl group which may be substituted; X is formula: --CHO or --CH.sub.2 OB (wherein B is a hydrogen atom or a protecting group of hydroxyl group); m and n independently are an integer of 0 or 1; provided that R.sup.4 is an alkanoyl group substituted by aryl, a sulfonyl group substituted by aryl having more than 9 carbon atoms or by lower alkyl, or a carbamoyl or thiocarbamoyl group which may be substituted when R.sup.1 is an unsubstituted lower alkyl, arylalkyl on methylthioethyl group, R.sup.2 and R.sup.3 independently are a lower alkyl or arylalkyl, X is --CHO, m is 1 and n is 0 or 1, or a salt thereof.

Abstract: The present invention relates to (1) a human angiotensin II type 1 receptor protein, a recombinant DNA containing a gene which codes for said protein, a transformant carrying said DNA, production of said protein, and anti-angiotensin II substance screening methods using transformants containing said protein.